These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 15694189)
1. Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma. Morris EC; Mackinnon S Best Pract Res Clin Haematol; 2005 Mar; 18(1):129-42. PubMed ID: 15694189 [TBL] [Abstract][Full Text] [Related]
2. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH; Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607 [TBL] [Abstract][Full Text] [Related]
3. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma. Sureda A Hematol Oncol Clin North Am; 2007 Oct; 21(5):943-60. PubMed ID: 17908630 [TBL] [Abstract][Full Text] [Related]
4. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A; J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703 [TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation for the non-Hodgkin's lymphomas and Hodgkin's disease. Hale GA; Phillips GL Cancer Treat Rev; 2000 Dec; 26(6):411-27. PubMed ID: 11139372 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic transplantation in lymphoma: current status. Schmitz N; Dreger P; Glass B; Sureda A Haematologica; 2007 Nov; 92(11):1533-48. PubMed ID: 18024402 [TBL] [Abstract][Full Text] [Related]
9. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059 [TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion. Todisco E; Castagna L; Sarina B; Mazza R; Anastasia A; Balzarotti M; Banna G; Tirelli U; Soligo D; Santoro A Eur J Haematol; 2007 Apr; 78(4):322-9. PubMed ID: 17253967 [TBL] [Abstract][Full Text] [Related]
11. Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma. Tomblyn M; Winter JN Expert Rev Anticancer Ther; 2003 Jun; 3(3):281-94. PubMed ID: 12820773 [TBL] [Abstract][Full Text] [Related]
12. Conventional allograft and autograft in low grade lymphoma. Avivi I; Goldstone AH Best Pract Res Clin Haematol; 2005 Mar; 18(1):113-28. PubMed ID: 15694188 [TBL] [Abstract][Full Text] [Related]
13. Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma? Ho AY; Pagliuca A Hematology; 2002 Dec; 7(6):345-54. PubMed ID: 12475739 [TBL] [Abstract][Full Text] [Related]